8.39
price down icon1.99%   -0.17
after-market Dopo l'orario di chiusura: 8.24 -0.15 -1.79%
loading
Precedente Chiudi:
$8.56
Aprire:
$8.52
Volume 24 ore:
1.00M
Relative Volume:
0.71
Capitalizzazione di mercato:
$1.31B
Reddito:
$53.61M
Utile/perdita netta:
$-142.52M
Rapporto P/E:
-7.5586
EPS:
-1.11
Flusso di cassa netto:
$-141.83M
1 W Prestazione:
+4.74%
1M Prestazione:
+22.84%
6M Prestazione:
-30.14%
1 anno Prestazione:
+36.42%
Intervallo 1D:
Value
$8.325
$8.58
Intervallo di 1 settimana:
Value
$7.69
$8.73
Portata 52W:
Value
$5.04
$16.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Name
Nome
Wave Life Sciences Ltd
Name
Telefono
617-949-2900
Name
Indirizzo
7 STRAITS VIEW, SINGAPORE
Name
Dipendente
288
Name
Cinguettio
@WAVELifeSci
Name
Prossima data di guadagno
2025-03-04
Name
Ultimi documenti SEC
Name
WVE's Discussions on Twitter

Confronta WVE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
WVE
Wave Life Sciences Ltd
8.39 1.33B 53.61M -142.52M -141.83M -1.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-16 Iniziato Citigroup Buy
2025-06-11 Ripresa Raymond James Outperform
2025-04-29 Iniziato Cantor Fitzgerald Overweight
2025-04-08 Iniziato Wedbush Outperform
2025-02-25 Iniziato Jefferies Buy
2024-10-16 Aggiornamento Raymond James Outperform → Strong Buy
2024-09-27 Ripresa JP Morgan Overweight
2024-09-19 Iniziato B. Riley Securities Buy
2024-09-09 Iniziato JP Morgan Overweight
2024-05-15 Iniziato Wells Fargo Overweight
2023-12-19 Aggiornamento Leerink Partners Market Perform → Outperform
2023-07-05 Iniziato Raymond James Outperform
2023-05-24 Downgrade Jefferies Buy → Hold
2020-12-15 Ripresa H.C. Wainwright Buy
2020-10-23 Iniziato RBC Capital Mkts Sector Perform
2019-12-31 Downgrade SVB Leerink Outperform → Mkt Perform
2019-11-01 Iniziato Guggenheim Buy
2019-07-15 Iniziato Cowen Market Perform
2019-04-17 Reiterato H.C. Wainwright Buy
2018-08-07 Iniziato Stifel Buy
2018-07-23 Iniziato H.C. Wainwright Buy
2018-03-19 Reiterato Mizuho Buy
2017-02-15 Iniziato H.C. Wainwright Buy
2016-11-10 Ripresa Leerink Partners Outperform
2015-12-07 Iniziato JMP Securities Mkt Outperform
2015-12-07 Iniziato Jefferies Buy
2015-12-07 Iniziato Leerink Partners Outperform
2015-12-07 Iniziato Sun Trust Rbsn Humphrey Buy
Mostra tutto

Wave Life Sciences Ltd Borsa (WVE) Ultime notizie

pulisher
Jul 24, 2025

What risks could impact Wave Life Sciences Ltd. stock performanceConsistently exceptional gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Is Wave Life Sciences Ltd. a good long term investmentLightning-fast growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025 - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

Wave Life Sciences to Host Webcast for Q2 2025 Financial Results and Business Updates - Quiver Quantitative

Jul 23, 2025
pulisher
Jul 22, 2025

Why Wave Life Sciences Ltd. stock attracts strong analyst attentionFree Join Group - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Wave Life Sciences Ltd. stockRemarkably fast returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Wave Life Sciences Ltd. stock priceFree Investment Portfolio Suggestions - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Wave Life Sciences Ltd. Stock Analysis and ForecastAccelerated financial growth - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

(WVE) Investment Analysis - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 19, 2025

WAVE Life Sciences (NASDAQ:WVE) Research Coverage Started at Citigroup - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

Will WAVE's Q1 2025 forecast meet expectations? - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

When is the best time to buy Wave Life Sciences Ltd. stockReturn Maximized Portfolio Strategy - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

WAVE Life Sciences Receives Buy Rating and USD 16 Price Target from Citigroup - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Wave Life Sciences’ SWOT analysis: RNA editing stock poised for breakthrough - Investing.com Australia

Jul 18, 2025
pulisher
Jul 17, 2025

Jessica Chen - White & Case LLP

Jul 17, 2025
pulisher
Jul 16, 2025

Breaking Down WAVE Life Sciences: 4 Analysts Share Their Views - Benzinga

Jul 16, 2025
pulisher
Jul 16, 2025

Citi initiates coverage on WAVE Life Sciences stock with Buy rating - Investing.com Australia

Jul 16, 2025
pulisher
Jul 16, 2025

Citi initiates coverage on WAVE Life Sciences stock with Buy rating By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Wave Life Sciences Ltd. stock price move sharplyFree Stock Index Interpretation - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey

Jul 15, 2025
pulisher
Jul 12, 2025

Leerink Partners Reiterates a Buy Rating on Wave Life Sciences (WVE), Keeps the PT at $24 - Yahoo Finance

Jul 12, 2025
pulisher
Jul 11, 2025

Wave Life Sciences stock reiterated Overweight by Cantor Fitzgerald - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 10, 2025

How the (WVE) price action is used to our Advantage - news.stocktradersdaily.com

Jul 10, 2025
pulisher
Jul 09, 2025

Huntington's Disease Pipeline 2025: MOA, ROA, And Clinical Trial Insights Explored By Delveinsight Spark Therapeutics, Chong Kun Dang Pharma, Neuvivo, Uniqure Biopharma, Wave Life Sciences, Novartis - Menafn.com

Jul 09, 2025
pulisher
Jul 07, 2025

Wave Life Sciences: Upgrading Rating To Buy After Turbulent 10 Months (NASDAQ:WVE) - Seeking Alpha

Jul 07, 2025
pulisher
Jul 07, 2025

We Think Wave Life Sciences (NASDAQ:WVE) Needs To Drive Business Growth Carefully - simplywall.st

Jul 07, 2025
pulisher
Jul 07, 2025

Wave Life Sciences: Speculative, But Promising (NASDAQ:WVE) - Seeking Alpha

Jul 07, 2025
pulisher
Jul 03, 2025

H.C. Wainwright Reaffirms Buy Rating on Wave Life Sciences After ADA Data Release - Insider Monkey

Jul 03, 2025
pulisher
Jun 24, 2025

Wave Life Sciences’ SWOT analysis: RNA editing stock faces fierce competition - Investing.com

Jun 24, 2025
pulisher
Jun 23, 2025

WVE: Wedbush Reiterates Outperform Rating on WAVE Life Sciences | WVE Stock News - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Wave Life sciences stock rating reiterated by Cantor Fitzgerald - Investing.com India

Jun 23, 2025
pulisher
Jun 21, 2025

Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007's Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions - The Manila Times

Jun 21, 2025
pulisher
Jun 20, 2025

Wave Life Sciences reports promising obesity treatment data By Investing.com - Investing.com Nigeria

Jun 20, 2025
pulisher
Jun 17, 2025

Wave Life Sciences’s SWOT analysis: RNA editing pioneer faces fierce competition - Investing.com Canada

Jun 17, 2025

Wave Life Sciences Ltd Azioni (WVE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):